tiprankstipranks
Advertisement
Advertisement
Midday Fly By: Target, Lowe’s, TJX report Q1 beats
PremiumThe FlyMidday Fly By: Target, Lowe’s, TJX report Q1 beats
23d ago
ImmunityBio announces FDA acceptance of supplemental BLA for ANKTIVA
Premium
The Fly
ImmunityBio announces FDA acceptance of supplemental BLA for ANKTIVA
24d ago
ImmunityBio announces results from ITC analyses of NAI with BCG
Premium
The Fly
ImmunityBio announces results from ITC analyses of NAI with BCG
25d ago
ImmunityBio reports Q1 EPS (62c) vs (15c) last year
PremiumThe FlyImmunityBio reports Q1 EPS (62c) vs (15c) last year
1M ago
ImmunityBio presents new comparison results on Anktiva, TAR-200
Premium
The Fly
ImmunityBio presents new comparison results on Anktiva, TAR-200
1M ago
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
Premium
Company Announcements
ImmunityBio Targets Tough Pancreatic Cancer With New Phase 1 Combo Trial
1M ago
ImmunityBio Addresses FDA Warning on ANKTIVA Promotion
PremiumCompany AnnouncementsImmunityBio Addresses FDA Warning on ANKTIVA Promotion
2M ago
ImmunityBio addresses FDA correspondence, reaffirms commitment to ad compliance
Premium
The Fly
ImmunityBio addresses FDA correspondence, reaffirms commitment to ad compliance
2M ago
ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up
Premium
Weekend Updates
ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100